Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-16
2011-08-16
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S527000
Reexamination Certificate
active
07998998
ABSTRACT:
Disclosed herein are compounds having a formula: (I) Compositions, methods, and medicaments related thereto are also disclosed.
REFERENCES:
patent: 2005/0009840 (2005-01-01), Cui et al.
patent: 0483667 (1992-05-01), None
patent: WO 03/008377 (2003-01-01), None
patent: WO 2005/108360 (2005-11-01), None
“Glaucoma.” URL: http://www.webmd.com/eye-health/glaucoma-eyes Nov. 1, 2010.
U.S. Appl. No. 11/836,655, filed Aug. 9, 2007, David W. Old.
U.S. Appl. No. 11/553,143, filed Oct. 26, 2006, Yariv Donde.
Prodrugs and Drug Delivery Systems, which is a chapter in Richard B. Silverman, Organic Chemistry of Drug Design and Drug Action, 2d Ed., Elsevier Academic Press: Amsterdam, 2004, pp. 496-557.
Ngo Vinh X.
Old David W.
Allergan Inc.
Anderson Rebecca
Ene Doina G.
Forrestal Kevin J.
Shterengarts Samantha
LandOfFree
Therapeutic substituted lactams does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic substituted lactams, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic substituted lactams will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2699195